Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin glargine versus human NPH insulin in type 2 diabetes mellitus
2004-002730-19Phase 4Completed
- Sponsor
- Sanofi
- Start
- Feb 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sanofi. Started Feb 2005; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-002730-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002730-19.